Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) Return on Equity (2019 - 2025)

Historic Return on Equity for Revolution Medicines (RVMD) over the last 7 years, with Q3 2025 value amounting to 0.56%.

  • Revolution Medicines' Return on Equity fell 2000.0% to 0.56% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.56%, marking a year-over-year decrease of 2000.0%. This contributed to the annual value of 0.29% for FY2024, which is 500.0% up from last year.
  • According to the latest figures from Q3 2025, Revolution Medicines' Return on Equity is 0.56%, which was down 2000.0% from 0.41% recorded in Q2 2025.
  • In the past 5 years, Revolution Medicines' Return on Equity registered a high of 0.2% during Q2 2021, and its lowest value of 0.56% during Q3 2025.
  • Moreover, its 5-year median value for Return on Equity was 0.32% (2025), whereas its average is 0.34%.
  • Per our database at Business Quant, Revolution Medicines' Return on Equity surged by 3200bps in 2021 and then plummeted by -2200bps in 2022.
  • Quarter analysis of 5 years shows Revolution Medicines' Return on Equity stood at 0.3% in 2021, then fell by -21bps to 0.36% in 2022, then increased by 10bps to 0.33% in 2023, then grew by 4bps to 0.31% in 2024, then tumbled by -77bps to 0.56% in 2025.
  • Its Return on Equity was 0.56% in Q3 2025, compared to 0.41% in Q2 2025 and 0.32% in Q1 2025.